Related Experiment Videos
Dissecting p53 tumor suppressor functions in vivo
Clemens A Schmitt1, Jordan S Fridman, Meng Yang
1Cold Spring Harbor Laboratory, 1 Bungtown Road, Cold Spring Harbor, New York 11724, USA.
Cancer Cell
|June 28, 2002
Summary
Disrupting apoptosis downstream of the p53 tumor suppressor gene provides a selective advantage in lymphoma development. This indicates apoptosis is the key p53 function selected against, not cell-cycle checkpoints.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- The p53 tumor suppressor protein regulates critical cellular processes like proliferation and survival.
- The specific functions of p53 that are essential for tumor suppression and are selected against during tumor development are not fully understood.
Purpose of the Study:
- To identify which p53 functions are essential for tumor suppression by examining selective pressures during lymphoma development.
- To determine if apoptosis or cell-cycle checkpoints are the primary p53 functions targeted during lymphomagenesis.
Main Methods:
- Utilized a mouse model with genetically modified myc-driven lymphomas.
- Investigated the impact of disrupting apoptosis downstream of p53 using Bcl2 or dominant-negative caspase 9.
- Compared the phenotypes of apoptosis-defective lymphomas with p53-null lymphomas.
Main Results:
- Disruption of apoptosis downstream of p53 conferred a selective advantage, mimicking p53 loss.
- Apoptosis-defective lymphomas with intact p53 showed an aggressive phenotype but lacked the characteristic checkpoint defects and aneuploidy of p53 mutant tumors.
- Inactivation of p53 was not required for lymphomagenesis when apoptosis was disrupted.
Conclusions:
- Apoptosis is the sole p53 function selected against during lymphoma development.
- Cell-cycle checkpoint defects and aneuploidy observed in p53 mutant tumors are byproducts, not primary targets, of p53 loss during lymphomagenesis.